Guangdong Lifestrong Pharmacy Co. Ltd. Working Capital to Net Assets Ratio
Guangdong Lifestrong Pharmacy Co. Ltd. working capital to net assets ratio. Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a Working Capital to Net Assets ratio of 80.6% as of June 2026. Working capital of CN¥608.75 Million (current assets of CN¥725.17 Million minus current liabilities of CN¥116.41 Million) is measured against net assets of CN¥754.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)
Working capital to net assets ratio of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025. This chart shows how Guangdong Lifestrong Pharmacy Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 80.6%, reflecting working capital of CN¥608.75 Million against net assets of CN¥754.84 Million CNY. See Guangdong Lifestrong Pharmacy Co. Ltd. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Guangdong Lifestrong Pharmacy Co. Ltd. Working Capital to Net Assets Ratio by Year (2017–2025)
Guangdong Lifestrong Pharmacy Co. Ltd. working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Guangdong Lifestrong Pharmacy Co. Ltd. balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.7% | CN¥598.63 Million | CN¥751.22 Million | CN¥700.90 Million | CN¥102.28 Million | ▲ +24.9 pp |
| 2024 | 54.8% | CN¥420.34 Million | CN¥766.75 Million | CN¥515.20 Million | CN¥94.85 Million | ▼ -2.2 pp |
| 2023 | 57.0% | CN¥443.69 Million | CN¥778.21 Million | CN¥509.66 Million | CN¥65.97 Million | ▼ -9.9 pp |
| 2022 | 66.9% | CN¥507.59 Million | CN¥758.67 Million | CN¥600.95 Million | CN¥93.36 Million | ▼ -18.7 pp |
| 2021 | 85.6% | CN¥642.77 Million | CN¥750.85 Million | CN¥708.84 Million | CN¥66.08 Million | ▲ +13.0 pp |
| 2020 | 72.7% | CN¥234.96 Million | CN¥323.41 Million | CN¥283.04 Million | CN¥48.08 Million | ▼ -2.9 pp |
| 2019 | 75.6% | CN¥205.35 Million | CN¥271.68 Million | CN¥251.32 Million | CN¥45.98 Million | ▲ +5.3 pp |
| 2018 | 70.3% | CN¥161.71 Million | CN¥229.97 Million | CN¥227.06 Million | CN¥65.35 Million | ▲ +13.3 pp |
| 2017 | 57.1% | CN¥94.93 Million | CN¥166.37 Million | CN¥209.14 Million | CN¥114.21 Million | — |